Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Post by bealerton Jun 18, 2023 5:24pm
199 Views
Post# 35502658

Thank you all for your recent posts

Thank you all for your recent postsEveryone has valid concerns about SBM and I agree that the 2 biggest problems are #1: CEO,
#2: The lame PR people that we waste tens of thousands of $$$ on for repeating basically nothing.
The press releases are obviously not exciting those we need to reach as the shitty share price shows. This is a disgusting price of 12.5 cents for where we are supposedly at in the science.  We are gonna fritter away another opportunity as the management again try to 'get it right'.  Obviously they haven't gotten it right yet and that's why we are down this low.

How many times do they expect us to be made fools of???

I think that the CFO has little sense of value for how they waste money and he should be stepping up to the plate just like the CEO.  

How many time are we going to get diluted?  We have over 1/4th billiion shares issued already.  That's a lot, folks.

Come on Sirona team. Grow up already and get a sense of urgency.

Hopefully you can somehow come up with a great deal out of the bio conference and get this fired up to new highs.

BeAlert
<< Previous
Bullboard Posts
Next >>